Abstract
The concept of precision cancer medicine emerged with a National Academics of Science report in 2011 describing the need and opportunity to classify human disease through a precision taxonomy. This new taxonomy would be based on the availability genomics data and other sources of big data to enable a more precise diagnosis and management of human disease. Since cancer is characterized by somatic and germline genetic changes, precision medicine has taken a natural direction that has included clinical oncology. This text includes contributions from leading researchers in the emerging and changing field of precision cancer medicine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Roychowdhury, S., Van Allen, E.M. (2019). Between Hype and Hope, on the Cutting Edge of Precision Cancer Medicine. In: Roychowdhury, S., Van Allen, E. (eds) Precision Cancer Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-23637-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-23637-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23636-6
Online ISBN: 978-3-030-23637-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)